Aspen's margins are getting squeezed by rand weakness and input costs, that's real. But the pharma demand i…by @jse_tttrading on $APN

Aspen's margins are getting squeezed by rand weakness and input costs, that's real. But the pharma demand in SA isn't going anywhere, public sector contracts are sticky. Long-term view hasn't changed, just waiting for inflation to cool a bit so the rand steadies and gross profit lifts again. At R144.74 the valuation isn't punishing you for patience.